Top Biotech Companies in Raleigh, NC (50)
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products.
GRAIL's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising across 2025 and into 2026, with Galleri driving year-over-year increases and volumes outpacing revenue. Feedback suggests growth accelerated in early 2026 as test adoption broadened.
Strategic Partnerships: Partnerships such as Epic EHR integration and a collaboration with Samsung for Asia expansion are expanding distribution and market access. These relationships also support commercialization through employers, health systems and digital-health channels.
Investor Backing & Capital Strength: A sizable cash balance and recent equity financing provide a substantial runway to fund R&D and commercial expansion. This capital position helps buffer the costs of scaling while regulatory review proceeds.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This...
Click Therapeutics's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Evidence indicates a $50 million Series D in April 2026 led by Boehringer Ingelheim, following a Series C in March 2025. This ongoing capital access, including dedicated commercialization funding, signals strong financial support for the next phase of growth.
Strategic Partnerships: Evidence indicates deep relationships with Boehringer Ingelheim and Otsuka, alongside new collaborations such as Ultrahuman for migraine-related technology. These alliances are described as enabling development, regulatory progress, and commercialization pathways across multiple programs.
Product Line Growth: Evidence indicates multiple FDA milestones—Rejoyn for major depressive disorder symptoms (2024), CT-132 for episodic migraine prevention (2025), and Motivista/CT-155 for negative symptoms of schizophrenia (2026)—plus expansion into obesity and cardiometabolic disease via acquired assets. These developments broaden the portfolio across therapeutic areas and advance late-stage candidates toward market.
Twenty years ago, we pioneered the world's first clear aligners. Since then, we have continuously innovated with new products and technologies that are revolutionizing treatments for doctors and their patients. Invisalign clear aligners and the iTero Intraoral scanner help dental professionals achieve the clinical results they expect and deliver effective, advanced dental options to their patients. Helping change millions of lives,...
Align Technology's Top Stability & Growth Strengths
Strong Market Position & Advantage: Invisalign is broadly viewed as the clear leader in doctor‑directed clear aligners, reinforced by a large trained‑doctor base and an integrated digital workflow. Record Q4/FY 2025 volumes and revenue, alongside industry characterization as the market leader, support advantage durability.
Market Expansion: International regions (EMEA, Latin America, APAC) are cited as driving year‑over‑year volume growth, with contributions from teen/kids and adult segments and growing DSO/OSO channels. Continued gains outside North America align with guidance for additional growth into 2026.
Innovation-Driven Growth: An integrated platform spanning Invisalign, iTero scanners, and exocad software underpins a closed‑loop workflow that encourages adoption. Ongoing iTero Lumina upgrades and plans for directly 3D‑printed retainers/attachments in 2026 indicate a pipeline that can sustain future growth.
Quanticate is a leading global data focused clinical research organisation (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. As experts in clinical data, Quanticate provides high quality teams that offer efficient outsourcing solutions for: • Clinical Data Management • Biostatistics • SAS Programming • Data quality oversight via Centralized Statistical Monitoring • Medical writing • Pharmacovigilance Quanticate can offer study level support, functional service provision...
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
Vallen is a leading provider of indirect industrial supplies—all those materials that are not part of the products our customers manufacture. From earplugs to specialty tools, to abrasives and cutting tools, we cover the vast majority of our customers’ maintenance, repair, operations and production-related needs. Vallen is also a leader in safety services with offerings that include equipment inspection, maintenance,...
Vallen USA's Top Stability & Growth Strengths
Market Expansion: Acquisition of Wesco’s Integrated Supply business for approximately $350 million expanded integrated-supply and MRO capabilities, and international scope grew with EES joining the European organization. National operations and expanded service capabilities enable support for larger industrial programs.
Investor Backing & Capital Strength: Ownership by Nautic Partners was explicitly positioned to accelerate the company’s growth trajectory and execute a defined growth plan. This backing aligns with continued hiring and added senior leadership in procurement and finance.
Strong Market Position & Advantage: National reach, a broad product-and-services mix, and industry listings (e.g., No. 18 among industrial distributors and No. 9 among MRO distributors) indicate a top-tier competitive position with leadership in integrated supply and safety services. The integrated-supply arm also describes itself as the largest integrated supply-services provider in the United States.
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Feedback suggests the company is in a stabilization and gradual recovery phase with expectations moving from low-single-digit toward mid-single-digit organic growth. The go-private transition is positioned to enable multi-year, sustainable improvements rather than short-term spikes.
Cost & Operational Efficiency: Operations are described as focusing on optimization, cost discipline, and AI-driven efficiencies through partnerships with Microsoft and KX. The approach emphasizes streamlining clinical and commercial workflows over broad headcount expansion.
Strategic Partnerships: Collaborations with technology providers like Microsoft and KX are highlighted as enablers of AI integration and efficiency gains. These alliances support a tech-enabled turnaround strategy across clinical and commercial functions.
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at...
Biogen's Top Stability & Growth Strengths
Product Line Growth: “Growth” medicines (e.g., Leqembi, Skyclarys, Zurzuvae, Qalsody) rose in 2025 and continued expanding in late 2025, indicating newer products are increasingly contributing to results. Leqembi and Skyclarys are specifically described as notable growth drivers, with ongoing lifecycle work (e.g., more convenient maintenance and subcutaneous dosing) supporting momentum.
Strong Market Position & Advantage: Biogen is positioned as a focused neurology frontrunner, leading or co-leading in select high-need niches such as early Alzheimer’s (with Eisai) and rare neurologic diseases (e.g., Friedreich’s ataxia; SOD1-ALS). Its neurology clinical and commercial infrastructure is described as providing scale and credibility that helps execute complex launches.
Strategic Partnerships: The Eisai partnership on Leqembi keeps Biogen at the forefront of disease-modifying Alzheimer’s therapy while reducing risk and capital intensity through shared economics and co-commercialization. Traditional FDA approval and broader Medicare coverage also supported access, reinforcing the partnership’s ability to translate regulatory wins into commercial opportunity.
Nixon Power Services is a power-generation company that distributes, designs, installs, and supports generator systems for industrial and commercial customers. It offers Rehlko (formerly Kohler) generators, along with rentals, parts, and aftermarket technical service. Its turnkey projects encompass engineering, construction, installation, commissioning, startup, and ongoing support for prime and standby power applications. The company operates across a multistate territory and...
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
Cellectis is a global, clinical-stage biopharmaceutical company. As pioneers and innovators in our field, we are driven by a single mission: to develop breakthrough treatments for patients with unmet medical needs. With 26 years of expertise, we operate a best-in-class genome editing platform focused on immuno-oncology and gene therapy. By leveraging our proprietary gene-editing technologies, we engineer allogeneic CAR-T cells designed...
Carolina Handling is a leading integrated material handling solutions provider in the Southeast. The company provides lift trucks and automation solutions for warehouses, manufacturing facilities, and distribution centers, offering a comprehensive range of products including racking, storage, lighting, and dock and door equipment, along with professional consulting and maintenance services.
Syngenta Group is a leading global agricultural technology (AgTech) company headquartered in Basel, Switzerland. With over 50,000 employees across more than 90 countries, it provides farmers with innovative technology and expertise to increase productivity and ensure the growth of healthy, affordable, and sustainable food. The company is a world market leader in sustainable agriculture, offering a diverse portfolio of seeds...
Palmer-Donavin Manufacturing Company is a privately-held construction material distribution company that engages in the wholesale distribution of residential building supplies and door fabrication. They are a leader in building material distribution, emphasizing exceptional customer service and employee ownership.
JF Petroleum Group is a leading provider of turnkey distribution, construction, and service solutions to the North American fueling infrastructure industry. The company serves a diverse clientele, including retail fueling stations, commercial and government fleets, and emergency power customers. With a national network of branches, they offer comprehensive support ranging from equipment supply and installation to 24/7 maintenance and compliance...
Established in 1953, Linder Industrial Machinery is recognized as one of the nation’s premier heavy equipment dealers. Linder, along with its’ dedicated team of employees, is committed to being a valued business partner to customers by offering quality new, used, and rental equipment across 27 branch locations in Florida, Georgia, North Carolina, South Carolina, and Virginia.
Xylem |ˈzīləm| 1) The tissue in plants that brings water upward from the roots; 2) a leading global water technology company. Xylem, a leading global water technology company dedicated to solving the world’s most challenging water issues, is the leading global provider of efficient, innovative and sustainable water technologies improving the way water is used, managed, conserved and re-used. Our international team is...
MMR Consulting Inc. and its dedicated team of experienced consultants are committed to delivering high quality, robust solutions for the Pharmaceutical and Biotechnology industries. Our expertise includes Engineering (Process, Automation, Facilities), Capital Project Management of large/complex projects and programs, Commissioning Qualification Validation, and GMP Compliance services.
.png)
































